A prospective, randomized, open-label study comparing the efficacy and safety of preprandial and prandial insulin in combination with acarbose in elderly, insulin-requiring patients with type 2 diabetes mellitus

Diabetes Technology and Therapeutics

Volumn 15, Issue 6, 2013, Pages 513-519

  Yang, Guang ^a   Li, Chunlin ^a   Gong, Yanping ^a   Li, Jian ^a   Cheng, Xiaoling ^a   Tian, Hui ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; GLUCOSE; INSULIN; ISOPHANE INSULIN;

ABDOMINAL DISTENSION; ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIABETIC PATIENT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXHAUSTION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCEMIC INDEX; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SELF MONITORING; TREATMENT DURATION; TREATMENT OUTCOME;

ACARBOSE; AGED; BLOOD GLUCOSE; CHINA; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84878613856     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0275     Document Type: Article

References (20)

1. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J; China National Diabetes and Metabolic Disorders Study Group: Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-1101.
2. Pan C, Tian H, Xu X, Lu J: Prevalence and incidence of diabetes in the elderly in Beijing Army [in Chinese]. Chin J Geriatr 2003;6:364-367.
3. Overmann H, Heinemann L: Injection-meal interval: recommendations of diabetologists and how patients handle it. Diabetes Res Clin Pract 1999;43:137-142. (Pubitemid 29155658)
4. Kelley DE, Bidot P, Freedman Z, Haag B, Podlecki D, Rendell M, Schimel D, Weiss S, Taylor T, Krol A, Magner J: Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes. Diabetes Care 1998;21:2056-2061. (Pubitemid 28549151)
5. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC: The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000;23:1108-1112.
6. Molnar GD, Taylor WF, Ho MM: Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability. Diabetologia 1972;8:342-348.
7. Muggeo M, Zoppini G, Bonora E, Brun E, Bonadonna RC, Moghetti P, Verlato G: Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care 2000;23:45-50. (Pubitemid 30022893)
8. Abe S, Inoue G, Yamada S, Irie J, Nojima H, Tsuyusaki K, Usui K, Atsuda K, Yamanouchi T: Two-way crossover comparison of insulin glargine and insulin detemir in basal-bolus therapy using continuous glucose monitoring. Diabetes Metab Syndr Obes 2011;4:283-288.
9. Rodbard D: Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther 2009;11(Suppl 1):S-55-S-67.
10. Schlichtkrull J, Munck O, Jersild M: The M-value, an index of glycemic control in diabetics. Acta Med Scand 1965;177: 95-102.
11. Takita M, Matsumoto S, Noguchi H, Shimoda M, Chujo D, Itoh T, Sugimoto K, Sorelle JA, Onaca N, Naziruddin B, Levy MF: Cluster analysis of self-monitoring blood glucose assessments in clinical islet cell transplantation for type 1 diabetes. Diabetes Care 2011;34:1799-1803.
12. Kohnert KD, Augstein P, Zander E, Heinke P, Peterson K, Freyse EJ, Hovorka R, Salzsieder E: Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents. Diabetes Care 2009;32:1058-1062.
13. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Clarke W: Symmetrization of the blood glucose measurement scale and its applications. Diabetes Care 1997;20:1655-1658. (Pubitemid 27463037)
14. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young- Hyman D, Schlundt D, Clarke W: Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the Low Blood Glucose Index. Diabetes Care 1998;21: 1870-1875. (Pubitemid 28478285)
15. Cox DJ, Gonder-Frederick LA: Progressive hypoglycemia's impact on driving simulation performance. Occurrence, awareness and correction. Diabetes Care 2000;23: 163-170. (Pubitemid 30071018)
16. Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W: Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 2006;29:2433-2438. (Pubitemid 44912248)
17. Kilpatrick ES, Rigby AS, Atkin SL: Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 2009;32:1901-1903.
18. Garg V: Noninsulin pharmacological management of type 1 diabetes mellitus. Indian J Endocrinol Metab 2011;15(Suppl 1):S5-S11.
19. Tamura Y, Araki A, Chiba Y, Horiuchi T, Mori S, Hosoi T: Postprandial reactive hypoglycemia in an oldest-old patient effectively treated with low-dose acarbose. Endocr J 2006;53:767-771. (Pubitemid 46045122)
20. Su JB, Wang XQ, Chen JF, Jin Y: Glycemic variability in insulin treated type 2 diabetes with well-controlled hemoglobin A1c and its response to further treatment with acarbose. Chin Med J (Engl) 2011;124:144-147.